Diamyd terminates liquidity provider agreement

Thu, Mar 04, 2010 08:20 CET

Due to increased turnover in the share Mangold Fondkommission AB will no longer act as liquidity provider in Diamyd Medical’s B-share. The current liquidity provider agreement will expire on March 5, 2010. A new liquidity provider has not been appointed.

Tags:

Diamyd Diamyd® vaccine shares

Diamyd terminates liquidity provider agreement

Documents & Links